Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University and Hadassah Hebrew University Medical Center, Jerusalem, Israel.
J Invest Dermatol. 2021 Dec;141(12):2944-2956.e6. doi: 10.1016/j.jid.2021.03.036. Epub 2021 Jun 26.
Almost half of the human microRNAs (miRNAs) are encoded in clusters. Although transcribed as a single unit, the levels of individual mature miRNAs often differ. The mechanisms underlying differential biogenesis of clustered miRNAs and the resulting physiological implications are mostly unknown. In this study, we report that the melanoma master transcription regulator MITF regulates the differential expression of the 99a/let-7c/125b-2 cluster by altering the distribution of RNA polymerase II along the cluster. We discovered that MITF interacts with TRIM28, a known inhibitor of RNA polymerase II transcription elongation, at the mIR-let-7c region, resulting in the pausing of RNA polymerase II activity and causing an elevation in mIR-let-7c expression; low levels of RNA polymerase II occupation over miR-99a and miR-125b-2 regions decreases their biogenesis. Furthermore, we showed that this differential expression affects the phenotypic state of melanoma cells. RNA-sequencing analysis of proliferative melanoma cells that express miR-99a and miR-125b mimics revealed a transcriptomic shift toward an invasive phenotype. Conversely, expression of a mIR-let-7c mimic in invasive melanoma cells induced a shift to a more proliferative state. We confirmed direct target genes of these miRNAs, including FGFR3, BAP1, Bcl2, TGFBR1, and CDKN1A. Our study demonstrates an MITF-governed biogenesis mechanism that results in differential expression of clustered 99a/let-7c/125b-2 miRNAs that control melanoma progression.
几乎一半的人类 microRNAs(miRNAs)都在簇中编码。尽管作为单个单元转录,但个别成熟 miRNAs 的水平通常不同。簇状 miRNAs 差异生物发生的机制及其产生的生理影响在很大程度上尚不清楚。在这项研究中,我们报告黑色素瘤主转录调节剂 MITF 通过改变 RNA 聚合酶 II 在簇中的分布来调节 99a/let-7c/125b-2 簇的差异表达。我们发现 MITF 在 mIR-let-7c 区域与 TRIM28 相互作用,TRIM28 是 RNA 聚合酶 II 转录延伸的已知抑制剂,导致 RNA 聚合酶 II 活性暂停,导致 mIR-let-7c 表达升高;miR-99a 和 miR-125b-2 区域的 RNA 聚合酶 II 占据水平低会降低它们的生物发生。此外,我们表明这种差异表达会影响黑色素瘤细胞的表型状态。表达 miR-99a 和 miR-125b 模拟物的增殖性黑色素瘤细胞的 RNA 测序分析显示,转录组向侵袭表型转移。相反,在侵袭性黑色素瘤细胞中表达 mIR-let-7c 模拟物会诱导向更增殖状态的转变。我们证实了这些 miRNAs 的直接靶基因,包括 FGFR3、BAP1、Bcl2、TGFBR1 和 CDKN1A。我们的研究表明,MITF 调控的生物发生机制导致簇状 99a/let-7c/125b-2 miRNAs 的差异表达,从而控制黑色素瘤的进展。